0.4362
price down icon1.20%   -0.0053
after-market アフターアワーズ: .45 0.0138 +3.16%
loading

Nexalin Technology Inc (NXL) 最新ニュース

pulisher
Mar 05, 2026

NXL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 05, 2026
pulisher
Mar 05, 2026

Hedge Fund Bets: What are analysts price targets for Nexalin Technology Inc Equity Warrant2025 Market WrapUp & Weekly Consistent Profit Watchlists - baoquankhu1.vn

Mar 05, 2026
pulisher
Feb 26, 2026

Nexalin Advances Pivotal HALO Clarity Trial for Insomnia - The Globe and Mail

Feb 26, 2026
pulisher
Feb 25, 2026

Nexalin Announces 150-Patient Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Nexalin (Nasdaq: NXL) advances pivotal HALO Clarity insomnia trial toward FDA de novo bid - Stock Titan

Feb 25, 2026
pulisher
Feb 24, 2026

Nasdaq Moves: Can Nexalin Technology Inc Equity Warrant continue delivering strong returns2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 24, 2026

Nexalin Launches Pivotal HALO Clarity Trial To Support Planned FDA Submission For Insomnia - Nasdaq

Feb 24, 2026
pulisher
Feb 24, 2026

Nexalin announces pivotal Halo(TM) Clarity trial - marketscreener.com

Feb 24, 2026
pulisher
Feb 24, 2026

Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market - The Manila Times

Feb 24, 2026
pulisher
Feb 24, 2026

Drug-free insomnia device trial targets 30 million adults - Stock Titan

Feb 24, 2026
pulisher
Feb 24, 2026

EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia - Bitget

Feb 24, 2026
pulisher
Feb 23, 2026

Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders - Bitget

Feb 23, 2026
pulisher
Feb 23, 2026

Nexalin Technology, Inc. Applauds Bipartisan Congressional Support for Deep Brain Neurostimulation Research and Expanding Access for Veterans - Quiver Quantitative

Feb 23, 2026
pulisher
Feb 23, 2026

Congress boosts brain stimulation research for veterans, with Nexalin involved - Stock Titan

Feb 23, 2026
pulisher
Feb 21, 2026

Can Nexalin Technology Inc. Equity Warrant be recession proofMarket Sentiment Summary & Reliable Momentum Entry Alerts - mfd.ru

Feb 21, 2026
pulisher
Feb 20, 2026

Will Nexalin Technology Inc. Equity Warrant outperform during market ralliesPortfolio Value Summary & Weekly High Conviction Ideas - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

Is Nexalin Technology Inc. stock forming a cup and handleShort Setup & Free Weekly Chart Analysis and Trade Guides - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Aug Intraday: Will Nexalin Technology Inc Equity Warrant outperform during market rallies2025 Buyback Activity & Consistent Income Trade Ideas - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 19, 2026

Breakout Move: What are CCTGs earnings expectations2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 16, 2026

NXL Should I Buy - Intellectia AI

Feb 16, 2026
pulisher
Feb 15, 2026

A | Can ONFO stock beat analyst upgradesJuly 2025 Highlights & Target Return Focused Picks - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

What’s Nexalin Technology Inc. Equity Warrant’s historical returnEarnings Recap Report & Weekly High Potential Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Will Nexalin Technology Inc. Equity Warrant stock benefit from sector rotation2025 AllTime Highs & Verified Stock Trade Ideas - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Market Leaders: Will Nexalin Technology Inc benefit from geopolitical trendsInflation Watch & Safe Capital Growth Stock Tips - baoquankhu1.vn

Feb 14, 2026
pulisher
Feb 14, 2026

NXL Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 14, 2026
pulisher
Feb 13, 2026

Nexalin Technology and First Phosphate Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Feb 13, 2026
pulisher
Feb 11, 2026

Aug Gainers: Is RSVR a turnaround storyJuly 2025 Macro Moves & Safe Capital Growth Plans - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

Nexalin Technology receives Nasdaq bid price deficiency notice - MSN

Feb 11, 2026
pulisher
Feb 11, 2026

Risk Hedge: Can Nexalin Technology Inc. Equity Warrant outperform in the next rallyJuly 2025 Reactions & Community Consensus Trade Signals - mfd.ru

Feb 11, 2026
pulisher
Feb 09, 2026

SEC Filings | Track, Search, and Analyze Public Company Disclosures - SECFilings.com

Feb 09, 2026
pulisher
Feb 08, 2026

Decliners Report: Can Nexalin Technology Inc deliver consistent dividendsWeekly Trend Recap & Daily Volume Surge Signals - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 07, 2026

Market Pulse: Will Nexalin Technology Inc benefit from geopolitical trendsQuarterly Growth Report & Technical Pattern Alert System - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 06, 2026

Nexalin Launches NeuroCare, An AI Virtual Clinic for Brain Health Disorders - AIM Media House

Feb 06, 2026
pulisher
Feb 06, 2026

Aug Drivers: Does Nexalin Technology Inc Equity Warrant have strong fundamentalsStop Loss & Verified High Yield Trade Plans - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 05, 2026

Nexalin Technology stock rises after launching AI-powered virtual clinic By Investing.com - Investing.com Australia

Feb 05, 2026
pulisher
Feb 05, 2026

Nexalin Technology stock rises after launching AI-powered virtual clinic - Investing.com

Feb 05, 2026
pulisher
Feb 05, 2026

Nexalin Technology, Inc. Launches NeuroCare® Virtual Clinic Platform in Collaboration with UC San Diego to Enhance Brain Health Treatment Access and Monitoring - Quiver Quantitative

Feb 05, 2026
pulisher
Feb 05, 2026

Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care - ChartMill

Feb 05, 2026
pulisher
Feb 05, 2026

EXCLUSIVE: Nexalin Launches AI-Powered Virtual Clinic For Brain Health For Home Settings - Benzinga

Feb 05, 2026
pulisher
Feb 03, 2026

Nexalin Expands Peer-Reviewed Evidence For DIFS Non-Invasive Brain Stimulation - Nasdaq

Feb 03, 2026
pulisher
Feb 02, 2026

Nexalin reports brain imaging studies validate its neurostimulation tech By Investing.com - Investing.com Nigeria

Feb 02, 2026
pulisher
Feb 02, 2026

Nexalin reports brain imaging studies validate its neurostimulation tech - Investing.com

Feb 02, 2026
pulisher
Feb 02, 2026

Nexalin Technology, Inc. Showcases Validation of DIFS™ Neurostimulation Technology Through Extensive Clinical Research - Quiver Quantitative

Feb 02, 2026
pulisher
Feb 02, 2026

Nexalin Highlights its Expanding Body of Peer-Reviewed - GlobeNewswire

Feb 02, 2026
pulisher
Feb 02, 2026

Nexalin Highlights its Expanding Body of Peer-Reviewed Neuroimaging Research Confirming its DIFS™ Technology as the Leader in Evidenced-Based Non-Invasive Brain Stimulation - Yahoo Finance

Feb 02, 2026
pulisher
Jan 31, 2026

Rate Hike: Should I invest in Nexalin Technology Inc Equity Warrant before earningsJuly 2025 Catalysts & Low Drawdown Momentum Ideas - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 31, 2026

CEO Moves: How is CRDA managing supply chain issuesWeekly Investment Report & AI Enhanced Trading Signals - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 29, 2026

Is Nexalin Technology Inc. likely to announce a buyback2025 Price Targets & Scalable Portfolio Growth Methods - mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

Does Nexalin Technology Inc. Equity Warrant have strong fundamentalsAnalyst Downgrade & Verified Entry Point Signals - mfd.ru

Jan 29, 2026
pulisher
Jan 28, 2026

What is Nexalin Technology Inc.’s book value per shareWeekly Stock Summary & Reliable Breakout Stock Forecasts - mfd.ru

Jan 28, 2026
pulisher
Jan 28, 2026

Nexalin Technology receives Nasdaq listing status notification - Medical Buyer

Jan 28, 2026
pulisher
Jan 27, 2026

Guidance Update: Is Nexalin Technology Inc a strong growth stock2025 Performance Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 27, 2026

Aug Action: What are analysts price targets for Nexalin Technology Inc Equity WarrantJuly 2025 News Drivers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Jan 27, 2026
medical_devices ZBH
$93.45
price down icon 2.40%
medical_devices STE
$238.51
price down icon 1.88%
$70.69
price down icon 3.03%
medical_devices PHG
$29.66
price down icon 4.11%
$77.11
price down icon 2.42%
medical_devices EW
$83.89
price down icon 1.56%
大文字化:     |  ボリューム (24 時間):